Association between the - 1031T/C polymorphism in tumor necrosis factor-alpha gene and unstable angina

Chinese Journal of Medical Genetics

Volumn 26, Issue 5, 2009, Pages 571-574

  Liu, Yan ^a   Jin, Wei ^a   Lu, Lin ^a   Chen, Qiu Jing ^a   Shen, Wei Feng ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Genetic polymorphism; Tumor necrosis factor alpha; Unstable angina

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CHINESE; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENE LOCUS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PROMOTER REGION; PROTEIN BLOOD LEVEL; UNSTABLE ANGINA PECTORIS;

ADULT; AGED; ANGINA, UNSTABLE; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; FEMALE; GENE FREQUENCY; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

ANGINA;

EID: 70350712243     PISSN: 10039406     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1003-9406.2009.05.021     Document Type: Article

References (21)

1. Berliner JA, Navab M, Fogelman AM, et al. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation, 1995, 91: 2488-2496.
2. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med, 1999, 340: 115-126.
3. Ahn SY, Cho CH, Park KG, et al. Tumor necrosis factor-alpha induces fractalkine expression preferentially in arterial endothelial cells and mithramycin A suppresses TNF-alpha-induced fractalkine expression. Am J Pathol, 2004, 164: 1663-1672.
4. Mechtcheriakova D, Schabbauer G, Lucerna M, et al. Specificity, diversity, and convergence in VEGF and TNF-alpha signaling events leading to tissue factor up-regulation via EGR-1 in endothelial cells. FASEB J, 2001, 15: 230-242. (Pubitemid 32061674)
5. Javed Q, Swanson N, Vohra H, et al. Tumor necrosis factor-alpha antibody eluting stents reduce vascular smooth muscle cell proliferation in saphenous vein organ culture. Exp Mol Pathol, 2002, 73: 104-111.
6. Gruber F, Hufnagl P, Hofer-Warbinek R, et al. Direct binding of Nur77/NAK-1 to the plasminogen activator inhibitor 1 (PAI-1) promoter regulates TNF alpha -induced PAI-1 expression. Blood, 2003, 101: 3042-3048. (Pubitemid 36857993)
7. Fernandez-Real JM, Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev, 2003, 24: 278-301. (Pubitemid 36724371)
8. Bernard V, Pillois X, Dubus I, et al. The -308 G/A tumor necrosis factor-alpha gene dimorphism: a risk factor for unstable angina. Clin Chem Lab Med, 2003, 41: 511-516. (Pubitemid 36592117)
9. Elahi MM, Gilmour A, Matata BM, et al. A variant of position - 308 of the Tumour necrosis factor alpha gene promoter and the risk of coronary heart disease. Heart Lung Circ, 2008, 17: 14-18. (Pubitemid 350246341)
10. Sbarsi I, Falcone C, Boiocchi C, et al. Inflammation and atherosclerosis: the role of TNF and TNF receptors polymorphisms in coronary artery disease. Int J Immunopathol Pharmacol, 2007, 20: 145-154. (Pubitemid 46506886)
11. Hou L, Huang J, Lu X, et al. Polymorphisms of tumor necrosis factor alpha gene and coronary heart disease in a Chinese Han population: interaction with cigarette smoking. Thromb Res, 2009, 123: 822-826.
12. Antonicelli R, Olivieri F, Cavallone L, et al. Tumor necrosis factor-alpha gene -308G>A polymorphism is associated with ST-elevation myocardial infarction and with high plasma levels of biochemical ischemia markers. Coron Artery Dis, 2005, 16: 489-493. (Pubitemid 44365936)
13. Shames BD, Barton HH, Reznikov LL, et al. Ischemia alone is sufficient to induce TNF-alpha mRNA and peptide in the myocardium. Shock, 2002, 17: 114-119.
14. Um JY, An NH, Kim HM. TNF-alpha and TNF-beta gene polymorphisms in cerebral infarction. J Mol Neurosci, 2003, 21: 167-171.
15. Koch W, Kastrati A, Bottiger C, et al. Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis, 2001, 159: 137-144. (Pubitemid 33016630)
16. Koch W, Tiroch K, von Beckerath N, et al. Tumor necrosis factor-alpha, lymphotoxin-alpha, and interleukin-10 gene polymorphisms and restenosis after coronary artery stenting. Cytokine, 2003, 24: 161-171. (Pubitemid 37297879)
17. Bis JC, Heckbert SR, Smith NL, et al. Variation in inflammation-related genes and risk of incident nonfatal myocardial infarction or ischemic stroke. Atherosclerosis, 2008, 198: 166-173.
18. Hassanzadeh M, Faridhosseini R, Mahini M, et al. Serum levels of TNF-, IL-6, and selenium in patients with acute and chronic coronary artery disease. Iran J Immunol, 2006, 3: 142-145. (Pubitemid 44784021)
19. Bennet AM, van Maarle MC, Hallqvist J, et al. Association of TNF-alpha serum levels and TNFA promoter polymorphisms with risk of myocardial infarction. Atherosclerosis, 2006, 187: 408-414. (Pubitemid 43963023)
20. Fargion S, Valenti L, Dongiovanni P, et al. TNF-alpha promoter polymorphisms. Methods Mol Med, 2004, 98: 47-58.
21. Morange PE, Tregouet DA, Godefroy T, et al. Polymorphisms of the tumor necrosis factor-alpha (TNF) and the TNF-alpha converting enzyme (TACE/ADAM17) genes in relation to cardiovascular mortality: the AtheroGene study. J Mol Med, 2008, 86: 1153-1161.